Inhibikase Therapeutics Inc (IKT)
Operating Cash Flow
-$42.61M
TTM · Period ending: · USD
IKT Operating Cash Flow
Latest reported-$42.61Mperiod ending
Latest reported-$42.61Mperiod ending
IKT TTM Operating Cash Flow (-$338.29K → -$42.61M)
TTM operating cash flow
High-resolution chart · PNG
IKT operating cash flow history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (USD) |
|---|---|
| -42,612,037 | |
| -35,742,656 | |
| -27,786,464 | |
| -25,616,066 | |
| -19,904,436 | |
| -19,384,579 | |
| -19,148,067 | |
| -17,244,923 | |
| -16,468,916 | |
| -15,979,931 | |
| -18,085,043 | |
| -18,198,986 | |
| -19,598,623 | |
| -19,389,036 | |
| -17,351,103 | |
| -17,890,546 | |
| -14,406,314 | |
| -14,297,028 | |
| -14,297,051 | |
| -11,147,762 | |
| -9,051,749 | |
| -4,815,902 | |
| -1,137,114 | |
| -184,213 | |
| -266,529 | |
| -305,000 | |
| -338,290 | |
| -280,711 | |
| -179,812 |